Michigan Pre-Seed Capital Fund taps Ann Arbor’s Biotectix

Another Ann Arbor-based start-up is getting a small shot in the arm from the state of Michigan. This time the Michigan Pre-Seed Capital Fund is investing in Biotectix. The bio-tech firm worked with Ann Arbor SPARK to win the investment and already has received investment dollars from Allied Minds. Biotectix, a University of Michigan spin-off, works with biomedical device manufacturers to develop and implement customized materials that improve the safety, longevity, reliability, biological interaction, and energy-efficiency of their devices. The company hopes to take a piece of the $2 billion biomaterials and active coatings pie.The Michigan Pre-Seed Fund money will be used to expand its business development activities. It will also accelerate research in the cardiac, neural and cochlear markets.Source: Biotectix and Ann Arbor SPARKWriter: Jon Zemke

Another Ann Arbor-based start-up is getting a small shot in the arm from the state of Michigan.

This time the Michigan Pre-Seed Capital Fund is investing in Biotectix. The bio-tech firm worked with Ann Arbor SPARK to win the investment and already has received investment dollars from Allied Minds.

Biotectix, a University of Michigan spin-off, works with biomedical device manufacturers to develop and implement customized materials that improve the safety, longevity, reliability, biological interaction, and energy-efficiency of their devices. The company hopes to take a piece of the $2 billion biomaterials and active coatings pie.

The Michigan Pre-Seed Fund money will be used to expand its business development activities. It will also accelerate research in the cardiac, neural and cochlear markets.

Source: Biotectix and Ann Arbor SPARK
Writer: Jon Zemke

Author

Our Partners

30044
30045
30046
30047
30049
Washtenaw ISD logo
Eastern Michigan University
Ann Arbor Art Center
UMS
U of M Arts Initiative
Engage EMU
Ann Arbor Housing Commission

Don't miss out!

Everything Ann Arbor and Ypsilanti, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.